Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.024 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |